119 related articles for article (PubMed ID: 15938386)
1. [The elder patient with advanced liver disease].
Hopf U
Praxis (Bern 1994); 2005 May; 94(18):743-50. PubMed ID: 15938386
[TBL] [Abstract][Full Text] [Related]
2. Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model.
Saab S; Hunt DR; Stone MA; McClune A; Tong MJ
Liver Transpl; 2010 Jun; 16(6):748-59. PubMed ID: 20517909
[TBL] [Abstract][Full Text] [Related]
3. Impact of etiological treatment on prognosis.
Su CW; Yang YY; Lin HC
Hepatol Int; 2018 Feb; 12(Suppl 1):56-67. PubMed ID: 28702738
[TBL] [Abstract][Full Text] [Related]
4. [Drug therapy in chronic liver disease].
Maier KP
Praxis (Bern 1994); 2005 Nov; 94(48):1907-12. PubMed ID: 16353688
[TBL] [Abstract][Full Text] [Related]
5. Advances in the treatment of hepatitis C.
Lawrence SP
Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
[TBL] [Abstract][Full Text] [Related]
6. Treatment of HBV related cirrhosis.
van Bömmel F; Berg T
Liver Int; 2013 Feb; 33 Suppl 1():176-81. PubMed ID: 23286862
[TBL] [Abstract][Full Text] [Related]
7. [Combined interferon, ribavirin treatment and the occurrence of hepatocellular carcinoma].
Lengyel G; Fehér J
Orv Hetil; 2010 Jul; 151(29):1177-81. PubMed ID: 20591786
[TBL] [Abstract][Full Text] [Related]
8. [Hepatology 2009].
Thimme R; Spangenberg HC; Blum HE
Dtsch Med Wochenschr; 2009 Jun; 134(25-26):1335-9. PubMed ID: 19517326
[No Abstract] [Full Text] [Related]
9. [Recurrent disease after liver transplantation. A therapeutic dilemma or treatable?].
Beckebaum S; Cicinnati VR; Broelsch CE; Gerken G
Med Klin (Munich); 2006 Dec; 101(12):939-50. PubMed ID: 17171317
[TBL] [Abstract][Full Text] [Related]
10. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
Schott E; Bergk A; Berg T
Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
[TBL] [Abstract][Full Text] [Related]
11. Antiviral treatment for cirrhosis due to hepatitis C: a review.
Somasundaram A; Venkataraman J
Singapore Med J; 2012 Apr; 53(4):231-5. PubMed ID: 22511042
[TBL] [Abstract][Full Text] [Related]
12. The indications for orthotopic liver transplantation.
MacDougall BR; Williams R
Transplant Proc; 1979 Mar; 11(1):247-51. PubMed ID: 222017
[No Abstract] [Full Text] [Related]
13. [Liver cirrhosis in adults: etiology and specific treatments].
Fartoux L; Serfaty L
Rev Prat; 2005 Sep; 55(14):1539-48. PubMed ID: 16255295
[TBL] [Abstract][Full Text] [Related]
14. Lamivudine for patients with chronic hepatitis B and advanced liver disease.
Liaw YF; Sung JJ; Chow WC; Farrell G; Lee CZ; Yuen H; Tanwandee T; Tao QM; Shue K; Keene ON; Dixon JS; Gray DF; Sabbat J;
N Engl J Med; 2004 Oct; 351(15):1521-31. PubMed ID: 15470215
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of lamivudine-adefovir therapy in chronic hepatitis B cirrhosis.
Lim SG; Aung MO; Mak B; Sutedja D; Lee YM; Lee GH; Fernandes M; Low HC; Lai V; Dan YY
J Clin Gastroenterol; 2011 Oct; 45(9):818-23. PubMed ID: 21921845
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of hepatitis C virus-related cirrhosis].
Bronowicki JP
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B220-4. PubMed ID: 12180292
[No Abstract] [Full Text] [Related]
17. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
Hui CK; Leung N; Shek WH; Zhang HY; Luk JM; Poon RT; Lo CM; Fan ST; Lau GK;
J Clin Gastroenterol; 2008; 42(5):533-8. PubMed ID: 18344885
[TBL] [Abstract][Full Text] [Related]
18. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
[TBL] [Abstract][Full Text] [Related]
19. [Chronic hepatitis C in HIV-HCV coinfected patients].
Gervais A
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B121-32. PubMed ID: 12180279
[No Abstract] [Full Text] [Related]
20. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.
Poon D; Anderson BO; Chen LT; Tanaka K; Lau WY; Van Cutsem E; Singh H; Chow WC; Ooi LL; Chow P; Khin MW; Koo WH;
Lancet Oncol; 2009 Nov; 10(11):1111-8. PubMed ID: 19880065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
